Citizens JMP raised the firm’s price target on Cushman & Wakefield to $16 from $15 and keeps an Outperform rating on the shares. Cushman & Wakefield’s Q2 report validates the merits of management’s strategic plan, based on strengthening the balance sheet, investing in producers, and leveraging its global capabilities to retain and grow its customer relationships, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CWK: